Aquapharm Biodiscovery
Drug discovery company developing products based on the chemical diversity of marine microorganisms
About Aquapharm Biodiscovery
AquaPharm Bio Discovery, founded in 2000 and based in Scotland, is a pioneering company in the field of marine biotechnology. The company focuses on discovering and developing new products derived from marine microorganisms. These microorganisms, found in the ocean, offer a vast and largely untapped resource for creating innovative solutions, particularly in drug development. AquaPharm operates from the European Centre for Marine Biotechnology in Oban, with additional corporate offices and laboratories in Edinburgh.
The company serves a diverse range of clients, including those in the pharmaceutical, nutraceutical (health supplements), cosmetics, and industrial sectors. AquaPharm's business model revolves around "bio prospecting," which means they search for new natural products from marine microbes. They then develop these products into commercially viable solutions. The company makes money by licensing these discoveries to other companies, forming strategic partnerships, and selling the developed products.
AquaPharm's unique approach combines advanced technologies and a deep understanding of marine biodiversity. This allows them to create a better platform for discovering new solutions compared to traditional chemical synthesis methods. They have a strong pipeline of new chemical leads and are actively working on high-yield bio-manufacturing of nutraceuticals, vitamins, antioxidants, industrial compounds, and more.
Their Oceanx business unit focuses on bringing scientifically backed ingredients and products to the food, beverage, and personal care markets. By leveraging their extensive collection of marine microbes, AquaPharm aims to provide innovative and effective solutions across multiple industries.
Source: Dealroom company dataAt a glance
- Founded
- 2000
- Headquarters
- Trondheim, Norway
- Sector
- Biotech & Life Sciences
News
Open roles
Aquapharm Biodiscovery in the Trondheim ecosystem
The Aquapharm Biodiscovery office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Scottish Enterprise Growth Investments
Aescap
Series B and later1 investor entered at this stage
Tate & Lyle Ventures
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Aquapharm Biodiscovery on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Aquapharm Biodiscovery on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

